BXP BXP, Inc.
Trophy office at about 9x FFO, but leverage, heavy leasing costs and rates cap the upside.
The story
BXP is the largest US trophy-office landlord (Boston, Manhattan, SF, DC, Seattle, LA), and it is benefiting from a flight to quality: premier Class A space is taking share while commodity office keeps losing tenants. Demand is improving as return-to-office mandates spread and AI tenants lease space in SF. The balance sheet is stretched, though. Net debt to EBITDA runs around 7.5x, refinancing costs are rising, and the 2024 dividend cut shows how much higher rates are eating into FFO. Development deliveries (life science, 343 Madison) and asset sales give some offset, but office leasing comes with heavy TI and leasing-commission costs.
Near-term FFO stays roughly flat because higher interest expense and occupancy lag offset development NOI. Long-run growth tracks inflation-level rent bumps, well below the 5.29% risk-free rate. The AFFO/FFO ratio sits at the low end of the range (0.68) because office leasing needs heavy TI, leasing commissions, and building capex. Beta of 1.2 is above the REIT anchor to reflect leverage, office-sector stigma, and rate sensitivity.
Value drivers
| AFFO growth (Y1) | 1.0% |
| Terminal AFFO growth | 2.5% |
| AFFO / FFO ratio | 68.0% |
| Beta | 1.20 |
| Failure probability | 3.0% |
| Cost of equity | 10.7% |
Valuation bridge
| PV of AFFO (explicit) | 5.34B |
| PV of terminal value | 4.51B |
| Equity value | 9.55B |
| ÷ shares → per share | $59.83 |
News
neutral +0.15 · 8 articles
- Is BXP (BXP) Still Trading At A Discount As Its Dividend Holds Firm?
- Data Centers Got the AI Hype—But Office REITs May Get the Rent Hikes
- Is BXP Stock Underperforming the Dow?
- BXP vs. NHI: Which Stock Is the Better Value Option?
- These 6 High-Yield Dividends May Be Too Good to Be True
- Here’s Why Baron Capital Reacquired BXP (BXP)
- The Office Boom Is Back. Can REITs Be Far Behind?
- Why Is Boston Properties (BXP) Down 3.7% Since Last Earnings Report?
Projected AFFO
| Yr | FFO | AFFO | Growth | PV |
|---|---|---|---|---|
| 1 | 1.24B | 844.64M | 1.0% | 763.05M |
| 2 | 1.26B | 854.49M | 1.2% | 697.38M |
| 3 | 1.27B | 865.88M | 1.3% | 638.41M |
| 4 | 1.29B | 878.87M | 1.5% | 585.39M |
| 5 | 1.31B | 893.52M | 1.7% | 537.66M |
| 6 | 1.34B | 909.90M | 1.8% | 494.62M |
| 7 | 1.36B | 928.10M | 2.0% | 455.78M |
| 8 | 1.39B | 948.21M | 2.2% | 420.67M |
| 9 | 1.43B | 970.33M | 2.3% | 388.90M |
| 10 | 1.46B | 994.59M | 2.5% | 360.12M |
Key risks
- Refinancing at higher rates squeezes FFO given leverage near 7.5x net debt/EBITDA
- Structural remote-work demand erosion and sublease overhang keep occupancy below 90%, especially in SF and Seattle
- Lab/life-science oversupply in Boston pressures development lease-up and yields
Catalysts
- Leasing recovery and occupancy gains at trophy assets as return-to-office mandates spread and AI tenants expand
- Asset sales and land monetization to deleverage, plus Fed rate cuts that narrow the cap-rate spread